PE-Backed 3SBio Seeks $711M In Hong Kong IPO
Chinese biotechnology company 3SBio, which was taken private by its CEO and a private equity firm in 2013, said Monday that it will seek up to HK$5.51 billion ($710.45 million) through...To view the full article, register now.
Already a subscriber? Click here to view full article